TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? [Forbes]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Forbes
The order imposed sweeping tariffs on drug companies that refuse to participate in his most-favored-nation (MFN) pricing initiative. The new tariffs are imposed under Section 232 of the Trade Expansion Act. This is different from the emergency-powers statute the Supreme Court invalidated earlier this year. MFN pricing requires drugmakers to charge U.S. buyers no more than the lowest price they offer to other comparable wealthy countries. This is a significant escalation in Trump's focus on drug prices. After months of voluntary deals with major drugmakers, the order makes it clear will use trade policy as an enforcement mechanism. Companies that play along get a three-year tariff reprieve. Those that don't face meaningful penalties. The move underscores the goal of TrumpRx , the direct-to-consumer drug portal that launched in February 2026 as well as its limits. The administration has now signed 17 MFN deals covering 86% of the branded pharmaceutical market. According to the Whi
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Highly contagious stomach bug spreads fast, hitting certain patients hardest [FOX News]FOX News
- Letters to the Editor: When a few buyers control most medications, all consumers suffer [Los Angeles Times (CA)]Los Angeles Times
- GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference CallBusiness Wire
- 3 Reasons GDRX is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- GoodRx vs. CVS vs. Costco: Where Retirees Save the Most on Prescriptions [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 4/24/26 - Form 8-K
- 4/15/26 - Form 4
- 4/15/26 - Form 4
- GDRX's page on the SEC website